Skip to main content

Atoltivimab / Maftivimab / Odesivimab Side Effects

Medically reviewed by Drugs.com. Last updated on Oct 24, 2024.

Applies to atoltivimab / maftivimab / odesivimab: parenteral concentrate for iv infusion.

Side effects include:

Most common adverse reactions (≥20%) are pyrexia, chills, tachycardia, tachypnea, vomiting.

More about atoltivimab / maftivimab / odesivimab

Patient resources

Other brands

Inmazeb

Professional resources

Other brands

Inmazeb

Related treatment guides

Further information

Atoltivimab/maftivimab/odesivimab side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.